Barbara A. Duncan

459 total citations
11 papers, 350 citations indexed

About

Barbara A. Duncan is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Barbara A. Duncan has authored 11 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Barbara A. Duncan's work include Cancer therapeutics and mechanisms (2 papers), Estrogen and related hormone effects (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). Barbara A. Duncan is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Estrogen and related hormone effects (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). Barbara A. Duncan collaborates with scholars based in United States, Switzerland and Ethiopia. Barbara A. Duncan's co-authors include Alan P. Siegal, Larry J. Schaaf, B. J. Kirby, M.F. Oliver, W. Lutz, K. W. Donald, Desmond G. Julian, Amarnath Sharma, F. Kerr and Donghua Yin and has published in prestigious journals such as The Lancet, Clinical Cancer Research and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Barbara A. Duncan

10 papers receiving 317 citations

Peers

Barbara A. Duncan
Danielle Armas United States
Heather Yvonne Small United Kingdom
Andrew Drexler United States
Ralf Beyrau Germany
Uche Anadu Ndefo United States
Barbara A. Duncan
Citations per year, relative to Barbara A. Duncan Barbara A. Duncan (= 1×) peers Pedro von Hafe

Countries citing papers authored by Barbara A. Duncan

Since Specialization
Citations

This map shows the geographic impact of Barbara A. Duncan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Duncan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Duncan more than expected).

Fields of papers citing papers by Barbara A. Duncan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Duncan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Duncan. The network helps show where Barbara A. Duncan may publish in the future.

Co-authorship network of co-authors of Barbara A. Duncan

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Duncan. A scholar is included among the top collaborators of Barbara A. Duncan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Duncan. Barbara A. Duncan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
3.
Yin, Donghua, Franzanne Vreeland, Larry J. Schaaf, et al.. (2007). Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy. Clinical Cancer Research. 13(3). 1000–1009. 56 indexed citations
4.
Gardner, Mark, et al.. (2006). Clinical Pharmacology of Multiple Doses of Lasofoxifene in Postmenopausal Women. The Journal of Clinical Pharmacology. 46(1). 52–58. 21 indexed citations
5.
Schaaf, Larry J., Lisa A. Hammond, Stuart J. Tipping, et al.. (2006). Phase 1 and Pharmacokinetic Study of Intravenous Irinotecan in Refractory Solid Tumor Patients with Hepatic Dysfunction. Clinical Cancer Research. 12(12). 3782–3791. 28 indexed citations
6.
Pitot, Henry C., Alex A. Adjei, Joel M. Reid, et al.. (2005). A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 58(2). 165–172. 23 indexed citations
7.
Rivera, Edgardo, et al.. (2004). Pilot Study Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of the Combination of Exemestane and Tamoxifen. Clinical Cancer Research. 10(6). 1943–1948. 15 indexed citations
8.
Vonderfecht, Steven, et al.. (2004). Myopathy Related to Administration of a Cationic Amphiphilic Drug and the Use of Multidose Drug Distribution Analysis to Predict its Occurrence. Toxicologic Pathology. 32(3). 318–325. 13 indexed citations
9.
Wolf, Daniel L., et al.. (2003). Pharmacokinetics and Renal Effects of Cidofovir with a Reduced Dose of Probenecid in HIV‐Infected Patients with Cytomegalovirus Retinitis. The Journal of Clinical Pharmacology. 43(1). 43–51. 37 indexed citations
10.
Duncan, Barbara A. & Alan P. Siegal. (1998). Early diagnosis and management of Alzheimer's disease.. PubMed. 59 Suppl 9. 15–21. 34 indexed citations
11.
Fulton, Mary, W. Lutz, K. W. Donald, et al.. (1972). NATURAL HISTORY OF UNSTABLE ANGINA. The Lancet. 299(7756). 860–865. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026